Erectile dysfunction (ED) is a common condition linked to aging and many risk factors such as asthma, heart disease, obesity, dyslipidemia, diabetes, hypogonadism, drug-related ED, and pelvic surgery. The metabolic syndrome, a multiplex risk factor for cardiovascular disease, includes all of these causes (CVD). CVD and ED have similar risk factors. In both conditions, endothelial dysfunction appears to be the early underlying pathophysiology. In several majors, randomized, double-blind, placebo-controlled clinical trials in the general population of men with ED, the effectiveness, tolerability, and cardiovascular safety of Fildena have been assessed.
Fildena purple pills are useful in a variety of patient groups, including those with difficult-to-treat conditions like diabetes mellitus and those who have had a radical prostatectomy. It’s linked to a fast onset of action (for certain guys, within 14 minutes) and a long time of action (up to 12 hours). Fildena increases men’s quality of life and happiness while still being well accepted and having a favorable safety profile. New research suggests that sildenafil can help with a variety of chronic disorders. Idiopathic pulmonary hypertension has been approved as a treatment. It has been proposed in several publications that it increases endothelial function and can play a role in premature ejaculation.